Does ISOSORBIDE MONONITRATE Cause Mobility decreased? 49 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Mobility decreased have been filed in association with ISOSORBIDE MONONITRATE (Isosorbide Mononitrate). This represents 1.9% of all adverse event reports for ISOSORBIDE MONONITRATE.
49
Reports of Mobility decreased with ISOSORBIDE MONONITRATE
1.9%
of all ISOSORBIDE MONONITRATE reports
0
Deaths
44
Hospitalizations
How Dangerous Is Mobility decreased From ISOSORBIDE MONONITRATE?
Of the 49 reports, 44 (89.8%) required hospitalization, and 1 (2.0%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ISOSORBIDE MONONITRATE. However, 49 reports have been filed with the FAERS database.
What Other Side Effects Does ISOSORBIDE MONONITRATE Cause?
Dizziness (554)
Headache (500)
Dyspnoea (462)
Chest pain (458)
Nausea (458)
Fatigue (446)
Diarrhoea (439)
Pruritus (416)
Myocardial infarction (409)
Malaise (405)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which ISOSORBIDE MONONITRATE Alternatives Have Lower Mobility decreased Risk?
ISOSORBIDE MONONITRATE vs ISOTRETINOIN
ISOSORBIDE MONONITRATE vs ISRADIPINE
ISOSORBIDE MONONITRATE vs ISTRADEFYLLINE
ISOSORBIDE MONONITRATE vs ITACITINIB
ISOSORBIDE MONONITRATE vs ITRACONAZOLE